Digital CBT-I for Chronic Insomnia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorWELT corp

About this trial

This study evaluates the effectiveness and safety of a digital Cognitive Behavioral Therapy program for Insomnia (CBT-I) in individuals with chronic insomnia. Participants will be randomly assigned to either begin digital CBT-I immediately or join a wait-list.

Eligibility criteria

Qualifiers

Meets diagnostic criteria for insomnia disorder according to the International Classification of Diseases, 10th Revision (ICD-10), including: F51: Nonorganic sleep disorders; G47: Sleep disorders

Has experienced insomnia symptoms for 3 months or longer.

Scores 8 or higher on the Insomnia Severity Index (ISI).

Oral and written fluency in Korean

Disqualifiers

Currently receiving non-pharmacological treatments for insomnia (e.g., CBT-I, light therapy, traditional medicine for sleep) within the past 3 months from screening.

Obstructive sleep apnea (G47.30)

Sleep behavior disorders

Restless leg syndrome (G28.8)

Trial design

Treatments tested in this trial

  • digital CBT-I

Treatment groups

120 Participants
are divided into 2 treatment groups

Locations

5
Inje University Ilsan Paik Hospital10380, Goyang-siGyeonggi-do, South Korea
Yongin Severance Hospital16995, Yongin-siGyeonggi-do, South Korea
Ewha Womans University Medical Center07804, SeoulSeoul, South Korea
Severance Hospital, Yonsei University Health System03722, SeoulSeoul, South Korea

Sponsors and collaborators

WELT corp

Lead sponsor